Eizen Joshua M — SEC insider filings

SEC reporting owner CIK 1949621. 14 insider filings on record with FilingPulse; latest filed 2026-11-06.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2022-10-28 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AN2 Therapeutics, Inc. (ANTX)See Remarks14—6 legs · 46,107 sh · $77,86216

Insider filings — Eizen Joshua M

FiledFormIssuerReported transactionsSource
2026-11-064AN2 Therapeutics, Inc. (ANTX)Sale (S): 2,826 @ $4.22EDGAR
2026-07-104AN2 Therapeutics, Inc. (ANTX)Sale (S): 5,945 @ $4.17EDGAR
2026-03-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 92,000 (derivative) · Disposition to issuer (D): 92,000 (derivative) · Grant/award (A): 50,150 (derivative) · Disposition to issuer (D): 50,150 (derivative)EDGAR
2026-02-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-01-074AN2 Therapeutics, Inc. (ANTX)Sale (S): 17,923 @ $1.00 · Sale (S): 6,931 @ $1.01EDGAR
2025-11-064AN2 Therapeutics, Inc. (ANTX)Sale (S): 2,819 @ $1.14EDGAR
2025-02-284AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 58,500 @ $0 · Grant/award (A): 117,000 (derivative) @ $0EDGAR
2025-01-074AN2 Therapeutics, Inc. (ANTX)Sale (S): 9,663 @ $1.34EDGAR
2024-11-054AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 31,500 @ $0 · Grant/award (A): 63,000 (derivative) @ $0EDGAR
2024-07-124AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 60,000 @ $0EDGAR
2024-03-294/AAN2 Therapeutics, Inc. (ANTX)Grant/award (A): 30,000 @ $0EDGAR
2024-03-184AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 30,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2023-02-174AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 50,150 (derivative) @ $0EDGAR
2022-10-284AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 92,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1949621 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs